CD133 suppression increases the sensitivity of prostate cancer cells to paclitaxel
Marjan Aghajani, Ahad Mokhtarzadeh, Leili Aghebati‐Maleki, Behzad Mansoori, Ali Mohammadi, Sahar Safaei, Zahra Asadzadeh, Khalil Hajiasgharzadeh, Vahid Khaze, Behzad Baradaran
Topics & Concepts
PaclitaxelGene silencingCancer researchLNCaPCancer stem cellCell growthViability assayPI3K/AKT/mTOR pathwayFlow cytometryCellCell cycleProtein kinase BCancer cellApoptosisMTT assayStem cellChemistryBiologyCancerMolecular biologyCell biologyBiochemistryGeneGeneticsCancer Cells and MetastasisMass Spectrometry Techniques and Applications3D Printing in Biomedical Research